Skip to main content

Month: January 2024

PREMIER DIVERSIFIED HOLDINGS INC. Reports on Delay in Filing of Annual Filings

Not for distribution to U.S. Newswire Services or for dissemination in the United States of America. Any failure to comply with this restriction may constitute a violation of U.S. Securities laws VANCOUVER, British Columbia, Jan. 18, 2024 (GLOBE NEWSWIRE) — Premier Diversified Holdings Inc. (“PDH” or the “Company”) (TSXV: PDH) is announcing that it has completed the filing of an application seeking a management cease trade order (the “MCTO”) under National Policy 12-203, from the British Columbia Securities Commission (“BCSC”). The Company has filed an application seeking an order for a MCTO from the BCSC because the Company may be unable to file its annual financial statements for the year ending September 30, 2023, including the related management’s discussion and analysis and certifications from the CEO...

Continue reading

Toll Brothers Opens Two Model Homes at The Ridge at Big Rock Community in Duvall, Washington

The Ridge at Big Rock by Toll BrothersToll Brothers announced the grand opening of two new model homes at its luxury home community in Duvall, Washington, The Ridge at Big Rock.The Ridge at Big Rock by Toll BrothersThe Ridge at Big Rock by Toll Brothers, a new pedestrian-friendly resort-style community, opens two brand new model homes in Duvall, Washington.DUVALL, Wash., Jan. 18, 2024 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, announced the highly anticipated opening of two brand new model homes at The Ridge at Big Rock, a new pedestrian-friendly community located only 12 miles from downtown Redmond in Duvall, Washington. The public is invited to attend a grand opening event to be held at the community this Saturday, January 20 from noon to 4pm PT. The professionally...

Continue reading

Nexus Industrial REIT Announces January and February Distributions

TORONTO, Jan. 18, 2024 (GLOBE NEWSWIRE) — Nexus Industrial REIT (“Nexus” or the “REIT”) (TSX: NXR.UN) announced today the declaration of the January and February 2024 distributions. The REIT will make a cash distribution in the amount of $0.05333 per unit, representing $0.64 per unit on an annualized basis, payable February 15, 2024 to unitholders of record as of January 31, 2024. The REIT will also make a cash distribution in the amount of $0.05333 per unit, representing $0.64 per unit on an annualized basis, payable March 15, 2024 to unitholders of record as of February 29, 2024. The REIT’s distribution reinvestment plan (“DRIP”) entitles eligible unitholders to elect to receive all, or a portion of the cash distributions of the REIT reinvested in units of the REIT. Eligible unitholders who so elect will receive a...

Continue reading

GH Research Announces Grant of European Patent Covering all Mebufotenin (5-MeO-DMT) and Mebufotenin Salt Products For Use in the Treatment of Major Depressive Disorder and Treatment-Resistant Depression

DUBLIN, Ireland, Jan. 18, 2024 (GLOBE NEWSWIRE) — GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders, today announced that it recently received a communication from the European Patent Office (EPO) that it has been granted a patent with claims directed to mebufotenin (5-MeO-DMT) or a pharmaceutically acceptable salt thereof for use in treating patients diagnosed with major depressive disorder (MDD) and treatment-resistant forms of MDD, such as treatment-resistant depression (TRD). The newly granted patent, EP3927337, which will have an effective date of February 14, 2024, and an expiry date of no earlier than 2040, is expected to cover all mebufotenin (5-MeO-DMT) and mebufotenin salt products for use in the treatment of MDD...

Continue reading

Kane Biotech Announces Special Meeting of Shareholders

WINNIPEG, Manitoba, Jan. 18, 2024 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company”, “Kane” or “Kane Biotech”) announces today that on February 20, 2024, the Company will hold a special meeting of its shareholders (the “Meeting”) to consider the election of Dr. Robert Huizinga as an additional director of the Company. The information circular and other materials with respect to the Meeting will be filed on SEDAR+ by the Company in due course. Dr. Huizinga is currently the principal of Reformation Consulting Services. He was formerly the Executive Vice-President of Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) and led the clinical development of voclosporin which had first year sales of $100 million USD. Prior to that, Dr. Huizinga was the Vice President of Clinical Affairs for Isotechnika Inc, and was a clinical...

Continue reading

Lincoln Electric Schedules Webcast for Fourth Quarter and Full Year 2023 Results

CLEVELAND, Jan. 18, 2024 (GLOBE NEWSWIRE) — Lincoln Electric Holdings, Inc., (the “Company”) (Nasdaq: LECO) announced today that it will release its fourth quarter and full year 2023 results on Thursday, February 15, 2024 prior to market open. An investor conference call and webcast will take place at 10:00 a.m. (ET) later that day. The event is available via webcast in listen-only mode and can be accessed here or on the Company’s Investor Relations home page at https://ir.lincolnelectric.com. To participate via telephone, please dial (888) 440-4368 (domestic) or (646) 960-0856 (international) and use confirmation code 6709091. Telephone participants are asked to connect 10 minutes prior to the start of the conference call. A replay of the earnings call will be available via webcast on the Company’s website. About Lincoln...

Continue reading

Aimei Health Technology Co., Ltd. Announces the Separate Trading of its Ordinary Shares and Rights Commencing January 22, 2024

NEW YORK, Jan. 18, 2024 (GLOBE NEWSWIRE) — Aimei Health Technology Co., Ltd. (“Aimei”) announced today that, commencing January 22, 2024, holders of the units sold in the Company’s initial public offering completed on December 6, 2023 may elect to separately trade the ordinary shares of Aimei, and the rights included in such units on The Nasdaq Global Market (“Nasdaq”). The ordinary shares and rights that are separated will trade on Nasdaq under the symbols “AFJK” and “AFJKR,” respectively. Those units not separated will continue to trade on Nasdaq under the symbol “AFJKU.” Holders of units will need to have their brokers contact Continental Stock Transfer & Trust Company, Aimei’s transfer agent, in order to separate the units into ordinary shares and rights. The units were initially offered by Aimei in an underwritten offering....

Continue reading

IsoEnergy Announces C$15 Million Bought Deal Private Placement

SASKATOON, Saskatchewan, Jan. 18, 2024 (GLOBE NEWSWIRE) — IsoEnergy Ltd. (“IsoEnergy” or the “Company”) (TSXV: ISO; OTCQX: ISENF) is pleased to announce that it has entered into an agreement with Eight Capital to act as co-lead underwriter and joint bookrunner on behalf a syndicate of underwriters (collectively, the “Underwriters”), including Haywood Securities Inc., as co-lead underwriter and joint bookrunner, pursuant to which the Underwriters will purchase for resale, on a “bought deal” basis, 2,400,000 federal flow-through common shares of the Company (the “Premium FT Shares”) at an offer price of $6.25 per Premium FT Share (the “Issue Price”), for aggregate gross proceeds of C$15,000,000 (the “Offering”). The Company has granted the Underwriters an option to purchase for resale up to an additional 15% of the Premium FT Shares...

Continue reading

White River Bancshares Co. Earns $788,000, or $0.79 Per Diluted Share, in Fourth Quarter 2023 and Earns $2.55 Million, or $2.56 Per Diluted Share for the Year; Highlighted by Double Digit Loan and Deposit Growth Year-Over-year

FAYETTEVILLE, Ark., Jan. 18, 2024 (GLOBE NEWSWIRE) — White River Bancshares Company (OTCQX: WRIV), (the “Company”) the holding company for Signature Bank of Arkansas (the “Bank”), today reported net income of $788,000, or $0.79 per diluted share, in the fourth quarter of 2023, compared to $1.42 million, or $1.42 per diluted share, in the fourth quarter of 2022. In the preceding quarter, the Company earned $639,000, or $0.64 per diluted share. All financial results are unaudited. “Our results for the fourth quarter of 2023 reflect solid growth in our loan portfolio, especially as our newer markets are becoming more established fixtures in their respective communities,” said Gary Head, Chairman and Chief Executive Officer. “A year ago, we invested in an expansion of our brand with new locations in Harrison and Jonesboro, in addition...

Continue reading

Mesa Air Group Enters New Agreements with United Airlines for Improved Operating and Financing Terms and Provides Update on CRJ-900 Asset Sale Program

PHOENIX, Jan. 18, 2024 (GLOBE NEWSWIRE) — Mesa Air Group, Inc. (NASDAQ: MESA) (“Mesa” or the “Company”) today announced agreements with United Airlines (“United”) to amend its capacity purchase agreement and certain credit agreements between the parties to significantly improve Mesa’s operating income and liquidity over the next twelve months. The Company also issued an update on its efforts to sell excess CRJ-900 assets to reduce debt and bolster liquidity. United Agreements Highlights:Increased block-hour rate in United CPA, retroactive to October 1, 2023 through December 31, 2024, projected to generate approximately $63.5 million in incremental revenue over next twelve months Extinguishment of $12.6 million of outstanding United bridge loan and revolving credit facility debt in exchange for Mesa’s vested equity investment...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.